Paul Finn, MD

For more than twenty-five years, Dr. Finn has been involved in the development, validation, and application of MRI techniques for cardiovascular imaging, many of which have made their way into mainstream clinical practice. He is Past-President of the International Society of Magnetic Resonance in Medicine (ISMRM) and a fellow of the American Institute for Medical and Biological Engineering (AIMBE). As PI or co-investigator on university, industrial and NIH-funded grants, Dr. Finn has provided leadership and supervision for multi-disciplinary academic and industrial research initiatives and have fostered collaboration and communication among imaging physicians and technical scientists at multiple institutions. He has led the development of broad-based cardiovascular advanced imaging programs at two academic medical centers and have interacted continuously with imaging physicians, referring clinicians and technical scientists.

 In recent years, his research has focused on the applications of ferumoxytol-enhanced MRI for cardiovascular diagnosis and on the development of novel approaches to exploit the unique properties of the agent. His group has shown that ferumoxytol is particularly powerful for imaging of complex congenital heart disease and vascular diseases.